Sol Silverman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sol Silverman has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Kathleen Vendrell Rankin
Department of Public Health Sciences, Baylor College of Dentistry, Texas A&M Health Science Center, Dallas, USA
2 shared publications - Alexander Ross Kerr
Department of Oral and Maxillofacial Pathology, Radiology and Medicine, College of Dentistry, New York University, New York, NY
1 shared publication - Daniel L. Jones
Department of Public Health, Sciences, The Texas A&M University Health Science Center Baylor College of Dentistry, Dallas, Texas 75246, USA
1 shared publication James P Scheetz
1 shared publication- Joel Brian Epstein
City of Hope National Medical Center, Duarte, CA 91010, USA
1 shared publication Norbert J Burzynski
University of Louisville, Kentucky, USA
1 shared publication
Latest Publications
- Open Access
- 5 March 2010
- Published by Springer Nature in Journal of Cancer Education
- Vol. 25 (3) , 279-281
Oral and Pharyngeal Cancer Control and Early Detection
Sixty-four standardized continuing education courses were given for dentists throughout the ten public health districts of the USA to determine if certain behaviors regarding oral and pharyngeal cancer (OPC) control could be modified. Questionnaires were obtained at baseline and at 6 months along with matched control groups. One thousand eight hundred two general dentists participated at baseline and 988 at a 6-month questionnaire follow-up. Analysis of the data indicated that continuing education courses had a positive influence on participants’ oral cancer attitudes, knowledge, and behavior that potentially could make a difference on prevention, early detection, and ultimately OPC control.
- 5 March 2010
- Published by Springer Nature in Journal of Cancer Education
- Vol. 25 (3) , 279-281
Open AccessOral and Pharyngeal Cancer Control and Early Detection
Sixty-four standardized continuing education courses were given for dentists throughout the ten public health districts of the USA to determine if certain behaviors regarding oral and pharyngeal cancer (OPC) control could be modified. Questionnaires were obtained at baseline and at 6 months along with matched control groups. One thousand eight hundred two general dentists participated at baseline and 988 at a 6-month questionnaire follow-up. Analysis of the data indicated that continuing education courses had a positive influence on participants’ oral cancer attitudes, knowledge, and behavior that potentially could make a difference on prevention, early detection, and ultimately OPC control.
- Open Access
- 5 March 2010
- Published by Springer Nature in Journal of Cancer Education
- Vol. 25 (3) , 277-278
Oral and Pharyngeal Cancer Control through Continuing Education
A standardized continuing education course was developed to determine if behavior in dental practices could be modified to improve office participation in oral and pharyngeal cancer control through early detection and tobacco-use cessation.
- 5 March 2010
- Published by Springer Nature in Journal of Cancer Education
- Vol. 25 (3) , 277-278
Open AccessOral and Pharyngeal Cancer Control through Continuing Education
A standardized continuing education course was developed to determine if behavior in dental practices could be modified to improve office participation in oral and pharyngeal cancer control through early detection and tobacco-use cessation.
- 1 September 2007
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 138, S41-S46
Mucosal Lesions in Older Adults
- 1 September 2007
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 138, S41-S46
Mucosal Lesions in Older Adults
- 1 February 2007
- Vol. 5, 13-21
Diagnosis and management of oral mucositis.
Oral mucositis is a common complication in cancer patients receiving chemotherapy and/or radiation therapy. Nearly all patients undergoing myeloablative therapy for stem-cell or bone marrow transplantation experience oral mucositis. Those receiving radiation therapy for head and neck cancer are at especially high risk. However,this toxicity also occurs with standard-dose chemotherapy and can be seen in association with treatment of many other tumor types. Oral mucositis significantly complicates cancer treatment by contributing to pain, dysphagia, weight loss, depression, higher risk of infection, decreased quality of life, and increased healthcare costs. This review summarizes the impact of oral mucositis in patients with cancer, including its pathogenesis, diagnosis, financial implications, and management. Current treatment guidelines are presented, and novel targeted therapies are discussed. Newer agents, such as palifermin (recombinant human keratinocyte growth factor-1), have been shown in clinical trials to reduce the incidence and severity of oral mucositis,and Saforis (an oral glutamine suspension) may also promote recovery from mucosal damage following chemotherapy or radiation therapy. Continued advances in understanding the pathobiology of oral mucositis should lead to the development of additional agents for its effective prevention and treatment in patients undergoing cancer therapy.
- 1 February 2007
- Vol. 5, 13-21
Diagnosis and management of oral mucositis.
Oral mucositis is a common complication in cancer patients receiving chemotherapy and/or radiation therapy. Nearly all patients undergoing myeloablative therapy for stem-cell or bone marrow transplantation experience oral mucositis. Those receiving radiation therapy for head and neck cancer are at especially high risk. However,this toxicity also occurs with standard-dose chemotherapy and can be seen in association with treatment of many other tumor types. Oral mucositis significantly complicates cancer treatment by contributing to pain, dysphagia, weight loss, depression, higher risk of infection, decreased quality of life, and increased healthcare costs. This review summarizes the impact of oral mucositis in patients with cancer, including its pathogenesis, diagnosis, financial implications, and management. Current treatment guidelines are presented, and novel targeted therapies are discussed. Newer agents, such as palifermin (recombinant human keratinocyte growth factor-1), have been shown in clinical trials to reduce the incidence and severity of oral mucositis,and Saforis (an oral glutamine suspension) may also promote recovery from mucosal damage following chemotherapy or radiation therapy. Continued advances in understanding the pathobiology of oral mucositis should lead to the development of additional agents for its effective prevention and treatment in patients undergoing cancer therapy.
- 1 November 2006
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 137, S22-S26
Antimicrobial mouthrinse as part of a comprehensive oral care regimen
- 1 November 2006
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 137, S22-S26
Antimicrobial mouthrinse as part of a comprehensive oral care regimen
- 1 January 2002
- Published by Human Kinetics
- Vol. 17 (2) , 83-4
Graduating dental students' perceptions of oral cancer education: results of an exit survey of seven dental schools.
A 22-question exit survey was administered on a voluntary basis to senior dental students at seven dental schools in order to evaluate perceptions regarding their knowledge and skills in oral cancer control. The questions encompassed prevention, role of tobacco, lesion recognition, diagnostic techniques, and patient management. The range of responses was broad between students as well as schools regarding didactic and clinical exposures, and confidence in abilities to manage oral cancer patients. Data from this survey showed a perceived lack of knowledge and skills among graduating dental students that may translate to a subsequent deficiency in incorporating optimal oral cancer control procedures in their practices.
- 1 January 2002
- Published by Human Kinetics
- Vol. 17 (2) , 83-4
Graduating dental students' perceptions of oral cancer education: results of an exit survey of seven dental schools.
A 22-question exit survey was administered on a voluntary basis to senior dental students at seven dental schools in order to evaluate perceptions regarding their knowledge and skills in oral cancer control. The questions encompassed prevention, role of tobacco, lesion recognition, diagnostic techniques, and patient management. The range of responses was broad between students as well as schools regarding didactic and clinical exposures, and confidence in abilities to manage oral cancer patients. Data from this survey showed a perceived lack of knowledge and skills among graduating dental students that may translate to a subsequent deficiency in incorporating optimal oral cancer control procedures in their practices.